Insight Molecular Diagnostics (IMDX) FCF Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 379.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 183.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1,284.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 454.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 97.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -192.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -537.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 590.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -71.00 |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.55 Mn |
| Dec 31, 2025 | -24,219.00 |
| Sep 30, 2025 | 274,896.00 |
| Jun 30, 2025 | 464,853.00 |
| Mar 31, 2025 | 190,231.00 |
| Dec 31, 2024 | 111,850.00 |
| Sep 30, 2024 | -413,726.00 |
| Jun 30, 2024 | -445,614.00 |
| Mar 31, 2024 | 60,484.00 |
| Dec 31, 2023 | -123,102.00 |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 374,171.00 |
| Mar 31, 2023 | -137,335.00 |
| Dec 31, 2022 | -5,395.00 |
| Sep 30, 2022 | -1.71 Mn |
| Jun 30, 2022 | -479,030.00 |
| Mar 31, 2022 | -47,135.00 |
| Dec 31, 2021 | 104,645.00 |
| Sep 30, 2021 | 2,056.00 |
| Jun 30, 2021 | 478,419.00 |